(PAYS) Paysign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US70451A1043

PAYS: Prepaid Cards, Digital Banking, Payment Processing

Paysign, Inc. (NASDAQ: PAYS) is a financial technology company specializing in prepaid card solutions, digital banking services, and integrated payment processing. The company serves businesses, consumers, and government institutions, offering a wide range of products such as corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, and demand deposit accounts with debit card access. Its solutions cater to industries like healthcare, pharmaceuticals, and municipalities, streamlining payments for clinical trials, consumer rebates, and healthcare reimbursement. Paysign operates under a B2B2C model, providing scalable, secure, and compliant payment solutions. The company, formerly known as 3PEA International, Inc., rebranded as Paysign in April 2019 and is headquartered in Henderson, Nevada.

From a technical perspective, Paysigns stock (NASDAQ: PAYS) is currently trading at $2.40, below its 20-day and 50-day simple moving averages (SMA) of $2.73 and $2.87, respectively. The 200-day SMA stands at $3.84, indicating a downtrend over the past year. The average true range (ATR) of $0.17 suggests low volatility. On the fundamental side, the company has a market cap of $197.06M, with a price-to-earnings (P/E) ratio of 26.29 and a forward P/E of 29.07. The price-to-book (P/B) ratio is 4.92, and the price-to-sales (P/S) ratio is 2.48. The return on equity (RoE) is 28.29%, reflecting efficient profitability relative to equity.

Three-Month Forecast: Based on the provided data, Paysigns stock is expected to face short-term headwinds due to its position below key moving averages. However, its strong RoE and reasonable forward P/E suggest potential for modest growth if the company demonstrates improved earnings or announces strategic partnerships. The low ATR indicates limited volatility, so price movements are likely to remain constrained. Overall, the stock may trade sideways with a slight upward bias if fundamentals improve.

Additional Sources for PAYS Stock

PAYS Stock Overview

Market Cap in USD 197m
Sector Technology
Industry Software - Infrastructure
GiC Sub-Industry Internet Services & Infrastructure
IPO / Inception 1998-04-02

PAYS Stock Ratings

Growth 5y -48.1%
Fundamental 79.3%
Dividend 0.0%
Rel. Strength Industry -22.5
Analysts 4.6/5
Fair Price Momentum 1.97 USD
Fair Price DCF 7.33 USD

PAYS Dividends

No Dividends Paid

PAYS Growth Ratios

Growth Correlation 3m -80.1%
Growth Correlation 12m -70.3%
Growth Correlation 5y -29.2%
CAGR 5y -12.45%
CAGR/Max DD 5y -0.14
Sharpe Ratio 12m -1.38
Alpha -31.94
Beta 1.33
Volatility 55.98%
Current Volume 163.5k
Average Volume 20d 226.9k
What is the price of PAYS stocks?
As of March 14, 2025, the stock is trading at USD 2.36 with a total of 163,539 shares traded.
Over the past week, the price has changed by -4.45%, over one month by -13.24%, over three months by -25.79% and over the past year by -22.37%.
Is Paysign a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Paysign (NASDAQ:PAYS) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 79.26 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PAYS as of March 2025 is 1.97. This means that PAYS is currently overvalued and has a potential downside of -16.53%.
Is PAYS a buy, sell or hold?
Paysign has received a consensus analysts rating of 4.60. Therefor, it is recommend to buy PAYS.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PAYS stock price target?
According to ValueRays Forecast Model, PAYS Paysign will be worth about 2.2 in March 2026. The stock is currently trading at 2.36. This means that the stock has a potential downside of -5.93%.
Issuer Forecast Upside
Wallstreet Target Price 6.8 188.6%
Analysts Target Price 6.8 188.6%
ValueRay Target Price 2.2 -5.9%